NewTimeSpace News: PEGBIO CO-B (02565.HK) announced on 10 July that it has entered into a memorandum of understanding with Nasdaq-listed Rani Therapeutics Holdings, Inc. The parties intend to leverage Rani’s proprietary RaniPill® oral biologic delivery platform to develop oral formulations for multiple innovative candidates targeting obesity and metabolic disorders, pursuing formulation differentiation based on multi-target metabolic modulators and long-acting pipeline assets. The MOU is valid for three years and non-binding; formal agreements will be executed for specific projects.
NewTimeSpace News: CHINA ART FIN (01572.HK) announced on 9 July that it plans to acquire 100% issued share capital of Sande Global Investment Management Limited, a Hong Kong licensed corporation holding SFC Type 1 (Dealing in Securities), Type 4 (Advising on Securities) and Type 9 (Asset Management) licences. A non-binding letter of intent has been signed while transaction terms remain under negotiation. The Group intends to upgrade the licences for virtual asset trading services and build an innovative “Art Finance + Real World Assets (RWA)” model. The exclusivity period lasts for 60 days. If completed, the acquisition may constitute a notifiable transaction. There is no guarantee the transaction will proceed.
NewTimeSpace News: HESAI-W (02525.HK) announced that the share subdivision became effective on 10 July, with subdivided Class B ordinary shares commencing trading on HKEX at 9:00 a.m. on the same day. The board lot size is changed from 20 existing Class B ordinary shares to 100 subdivided Class B ordinary shares. A temporary trading counter for 160 shares (in old share form) will be available between 10 July and 13 August. Exercise prices and quantities of outstanding options and unvested RSUs have been adjusted proportionately. New share certificates are coloured yellow.
NewTimeSpace News: UISEE TECH (01511.HK) announced on 10 July that it has secured a fresh order for 7 autonomous vehicles from Xinjiang Airport Group. The autonomous vehicle fleet deployed at Ürümqi Tianshan International Airport now totals over 70 units, forming the largest apron autonomous driving operation fleet in Chinese mainland. The existing fleet has achieved a milestone of 1 million kilometres of commercial operation.
NewTimeSpace News: EACON (07687.HK) announced on 9 July that it acted as the second completing entity for the project “Key Technologies and Application of Green, Intelligent, Safe and High-efficiency Mining for Large Open-pit Mines”, which has won the Second Prize of State Scientific and Technological Progress Award. This highest-level national government science and technology award recognises the Company’s technological strengths in mine intelligence and autonomous driving. Relevant technical outcomes align closely with the Group’s core unmanned mining solutions and are expected to lift brand influence and market competitiveness.
NewTimeSpace News: ESTUN (02715.HK) announced that the Company convened an employee representative congress on 9 July 2026. Mr Zhou Ailin was unanimously elected as employee representative director of the 6th Board of Directors via democratic election.
NewTimeSpace News: VSING (08292.HK) announced on 9 July that it plans to acquire all or part of equity interest in Golfzon Hong Kong, the largest and technologically advanced indoor golf operator in Hong Kong with 5 directly-operated outlets, over 60 franchise stores and more than 5,000 premium members. Both parties aim to finalise definitive agreements within three months. The memorandum of understanding is non-binding. The Group intends to create a brand-new "Technology + Sports + Social" entertainment ecosystem.
NewTimeSpace News: SIMCERE PHARMA (02096.HK) announced on 9 July that its Class 1 innovative drug Xibi Xin® (Edaravone and Dexborneol Concentrated Solution for Injection) has been included in the 2026 National Essential Medicines List for the treatment of acute ischaemic stroke. Already listed in national medical insurance, it is the sole neuroprotective agent recommended with Class IIa evidence in Chinese clinical guidelines and has benefited over 6 million AIS patients. The inclusion will accelerate penetration into grassroots medical markets.
NewTimeSpace News: HK SH ALLIANCE (01001.HK) announced on 9 July that its subsidiary’s tender submission for the government’s Tsing Yi Advanced Construction Industry Building project was unsuccessful. The Group stated that it has alternative operational arrangements in place and expects the tender result to exert no material adverse impact on its business operations and financial position. Shareholders and investors are advised to exercise caution.
NewTimeSpace News: The Hong Kong Stock Exchange (HKEX) issued a disciplinary statement on 9 July imposing reprimands and training orders on EVER REACH GP (03616.HK), four directors and five senior executives. The case stemmed from a RMB320 million circular fund arrangement, which delayed audit procedures and triggered trading suspension. The Company published all overdue financial results in July 2025 and resumed trading in September 2025. Relevant individuals are required to complete 21 hours of compliance training.
NewTimeSpace News: BAIYUNSHAN PH (00874.HK) announced on 9 July that Dexamethasone Sodium Phosphate Injection (1ml:5mg) manufactured by its controlled subsidiary Tianxin Pharmaceutical has passed the generic drug consistency evaluation. The domestic sales of this specification reached RMB236 million in 2025. The Group invested approximately RMB3.1678 million in relevant R&D. The approval is expected to boost product competitiveness, while uncertainties remain in production and sales.
NewTimeSpace News: CI FIN TECH GP (08029.HK) announced on 9 July that Executive Director Wang Qiang has been appointed Chairman of the Board and fellow Executive Director Zheng Meicheng Vice-chairwoman, with effect from 9 July 2026. Wang holds approximately 19.5% equity interest in the Company and receives monthly director remuneration of HK$80,000. Zheng, younger sister of former Chairman Zheng Dinggang, earns HK$150,500 per month.
NewTimeSpace News: Micot Pharma-B (02335.HK) announced on 9 July that the Phase II clinical trial of MT1002, the world’s first dual anticoagulant and antiplatelet peptide candidate, for anticoagulation in haemodialysis patients has completed first patient enrolment. The molecule exerts both anticoagulant and antiplatelet effects, featuring rapid onset and eliminating frequent monitoring requirements.
NewTimeSpace News: New Century Group Hong Kong Ltd. (00234.HK) announced on 9 July that its subsidiary Easy Cash Finance granted a HK$8.7 million mortgage loan to Wong Kwok Keung and Jiayuan Holdings for a term of 12 months with annual interest rate of 12%, secured by properties valued at HK$13.8 million. The borrowers are independent third parties. The transaction constitutes a discloseable transaction. The Group expects steady interest income and cash inflows from the loan.
NewTimeSpace News: Bank of Qingdao Co.,Ltd. (03866.HK) announced on 9 July that it has completed the issuance of RMB4 billion perpetual capital bonds. The coupon rate stands at 2.01% for the first five years and will be reset every five years. Proceeds will be used to supplement the Bank’s Additional Tier 1 Capital. Bookbuilding commenced on 7 July and the issuance was finalised on 9 July.
NewTimeSpace News: Tat Hong Equipment Service Co., Ltd. (02153.HK) announced on 9 July its 10th issuance of digital securities commercial paper (3-month SGD Series 010) carrying an annual interest rate of 4.40% with a tenor of approximately three months. The Group plans to raise SGD30 million to SGD35 million for working capital requirements. The instruments are issued as security tokens on the SDAX platform under its multi-currency CP programme.
